Where does Bardy Diagnostics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bardy Diagnostics, Inc. ranks #2,766 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bardy Diagnostics, Inc. hold?

Bardy Diagnostics, Inc. holds 139 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is Bardy Diagnostics, Inc.'s Innovation Score?

Bardy Diagnostics, Inc. has an Innovation Score of 47.5 out of 100 (top 18% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bardy Diagnostics, Inc. focus on?

Bardy Diagnostics, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 130 patents. Grants appear in 15 CPC subclasses total.

Is Bardy Diagnostics, Inc.'s patent grant rate increasing or decreasing?

Bardy Diagnostics, Inc.'s recent grant velocity is +18% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Bardy Diagnostics, Inc.'s patents?

Bardy Diagnostics, Inc.'s patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bardy Diagnostics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bardy Diagnostics, Inc.

USPTO PatentsView assignee record - 139 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bardy ranks #2,766 of 49,997 tracked US assignees by granted-patent volume, with 139 patents across 15 technology areas.

#2,766
of 49,997 US assignees by volume: Top 18%
by Innovation Score (47.5/100): 18.1
avg claims per patent: +18%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2766 · US Corporation #2,766 · 139 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 139 grants
TOP-DECILE #2,766/49,997
PHOTO-FINISH Bar-Ilan University
CPC-FOCUS A61B · 15 areas
INNOV-PAR 47.5/100
CLAIMS-RICH 18.1 claims/avg
TYPE-USCORP US Corporation
VEL-UP +18% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bar-Ilan University (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Sennheiser & KG · near

47
Bardy Diagnostics · this assignee

47
National Institute… · near

47
UNIVERSITÀ Degli… · near

47
Whirlpool · near

47
3D Lighting… · lowest

7

What this shows Bardy's Innovation Score is 47.5/100 (top 18% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Bardy's grants concentrate

Bardy Diagnostics, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 93.5% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (22 grants) versus a trough of 1 in 2015. By volume, Bardy sits between RealD Spark, LLC and Creative Technology Corporation.

Bardy's three-year grant acceleration

From 2019–2021 to 2022–2024, Bardy Diagnostics, Inc. moved from 49 to 43 grants (0.88x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,562. See the growth leaderboard.

Reald Spark

140
The United States…

140
Xencor

140
Bar-ilan Universi…

139
Beijing Institute…

139
Cytiva Sweden AB

139
Continuous Compos…

139
Creative Technolo…

139
Bardy Diagnostics ◀

139

What this shows Bardy holds 139 patents at rank #2,766, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bardy

By rank, the assignees closest to #2,766 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Bardy's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bardy, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Whirlpool S.A. 47 UNIVERSITÀ Degli Studi DI Roma “LA SAPIENZA” 47 National Institute Of Technology 47 Sennheiser electronic GmbH & Co. KG 47

Similar claim depth

Nearest assignees by average claims per patent (18.1 here).

Cambricon Technologies Corporation Limited 18.1 avg Coupa Software Incorporated 18.1 avg Guided Therapy Systems, LLC 18.1 avg Apical Limited 18.1 avg

Bardy's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 18% higher than 82% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bardy Diagnostics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	0.7%
2016	8	5.8%
2017	20	14.4%
2018	12	8.6%
2019	20	14.4%
2020	19	13.7%
2021	10	7.2%
2022	15	10.8%
2023	22	15.8%
2024	6	4.3%
2025partial year	6	4.3%

Which technologies does Bardy Diagnostics, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 130

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 49

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 15

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 11

G06F - Electric Digital Data Processing 9

G06N - Computing Arrangements Based ON Specific Computational Models 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 3

Y10T - Technical Subjects Covered BY Former US Classification 3

H03M - CODING; DECODING; Code Conversion IN General 3

H01F - MAGNETS; INDUCTANCES; TRANSFORMERS; Selection OF Materials FOR Their Magnetic Properties 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

H04Q - Selecting 1

H04W - Wireless Communication Networks 1

G16Y - Information AND Communication Technology Specially Adapted FOR THE Internet OF Things [IoT] 1

Top 15 of 15 technology areas

Where it ranks

Overall rank by patents

#2,766

of 49,997 tracked assignees

Innovation Score

47.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Bardy Diagnostics, Inc.'s patent record in context - here's where to go next.

Bardy Diagnostics, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 93.5% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #2,766 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bardy Diagnostics, Inc. against RealD Spark, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.